Evidence map›Paper›PMID 34841147›Full record

ArticleACS omega2021

Label-Free Assessment of the Drug Resistance of Epithelial Ovarian Cancer Cells in a Microfluidic Holographic Flow Cytometer Boosted through Machine Learning.

Lu Xin, Wen Xiao, Leiping Che, JinJin Liu, Lisa Miccio, Vittorio Bianco, Pasquale Memmolo, Pietro Ferraro, Xiaoping Li, Feng Pan

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Observational
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Lu XinKey Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation & Optoelectronic Engineering, Beihang University, Beijing 100191, China.
Wen XiaoKey Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation & Optoelectronic Engineering, Beihang University, Beijing 100191, China.
Leiping CheKey Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation & Optoelectronic Engineering, Beihang University, Beijing 100191, China.
JinJin LiuDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Lisa MiccioCNR, Institute of Applied Sciences & Intelligent Systems (ISASI) "E. Caianiello", via Campi Flegrei 34, 80078 Pozzuoli, Italy.ORCID https://orcid.org/0000-0001-9427-881X
Vittorio BiancoCNR, Institute of Applied Sciences & Intelligent Systems (ISASI) "E. Caianiello", via Campi Flegrei 34, 80078 Pozzuoli, Italy.ORCID https://orcid.org/0000-0003-1956-4976
Pasquale MemmoloCNR, Institute of Applied Sciences & Intelligent Systems (ISASI) "E. Caianiello", via Campi Flegrei 34, 80078 Pozzuoli, Italy.ORCID https://orcid.org/0000-0002-9607-7728
Pietro FerraroCNR, Institute of Applied Sciences & Intelligent Systems (ISASI) "E. Caianiello", via Campi Flegrei 34, 80078 Pozzuoli, Italy.ORCID https://orcid.org/0000-0002-0158-3856
Xiaoping LiDepartment of Obstetrics and Gynecology, Peking University People's Hospital, Beijing 100044, China.
Feng PanKey Laboratory of Precision Opto-mechatronics Technology, School of Instrumentation & Optoelectronic Engineering, Beihang University, Beijing 100191, China.ORCID https://orcid.org/0000-0002-3303-4317
Beihang University · CNInstitute of Applied Science and Intelligent Systems · ITPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

About 75% of epithelial ovarian cancer (EOC) patients suffer from relapsing and develop drug resistance after primary chemotherapy. The commonly used clinical examinations and biological tumor tissue models for chemotherapeutic sensitivity are time-consuming and expensive. Research studies showed that the cell morphology-based method is promising to be a new route for chemotherapeutic sensitivity evaluation. Here, we offer how the drug resistance of EOC cells can be assessed through a label-free and high-throughput microfluidic flow cytometer equipped with a digital holographic microscope reinforced by machine learning. It is the first time that such type of assessment is performed to the best of our knowledge. Several morphologic and texture features at a single-cell level have been extracted from the quantitative phase images. In addition, we compared four common machine learning algorithms, including naive Bayes, decision tree, K-nearest neighbors, support vector machine (SVM), and fully connected network. The result shows that the SVM classifier achieves the optimal performance with an accuracy of 92.2% and an area under the curve of 0.96. This study demonstrates that the proposed method achieves high-accuracy, high-throughput, and label-free assessment of the drug resistance of EOC cells. Furthermore, it reflects strong potentialities to develop data-driven individualized chemotherapy treatments in the future.

Identifiers

PMID34841147
PMCPMC8613806
OpenAlexW3212242689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.